Abstract
Spirochetes causing Lyme disease or relapsing fever exploit an array of sophisticated means to establish infection and to combat innate and adaptive immune responses of the human host. One central immune escape mechanism of serum-resistant spirochetes involves the inactivation of host complement attack through binding of distinct complement regulatory proteins, including factor H (CFH), factor H-like protein 1 (FHL1), factor H-related protein 1 (CFHR1), CFHR2, CFHR5, C4b-binding protein (C4Bp), and/or C1 esterase inhibitor (C1-Inh) to the cell surface (Fig. 4.1) (Alitalo et al. 2001; Bhide et al. 2009; Grosskinsky et al. 2009; Haupt et al. 2007; Hellwage et al. 2001; Kraiczy et al. 2001a, b; McDowell et al. 2003a; Pietikainen et al. 2010; Rossmann et al. 2007; Schott et al. 2010; Siegel et al. 2010; Stevenson et al. 2002; Meri et al. 2006).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Akins DR, Porcella SF, Popova TG, Shevchenko D, Baker SI, Li M, Norgard MV, Radolf JD (1995) Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue. Mol Microbiol 18(3):507–520
Alitalo A, Meri T, Ramo L, Jokiranta TS, Heikkila T, Seppala IJT, Oksi J, Viljanen M, Meri S (2001) Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect Immun 69(6):3685–3691
Alitalo A, Meri T, Chen T, Lankinen H, Cheng Z-Z, Jokiranta TS, Seppala IJT, Lahdenne P, Hefty PS, Akins DR et al (2004) Lysine-dependent multipoint binding of the Borrelia burgdorferi virulence factor outer surface protein E to the C terminus of factor H. J Immunol 172(10):6195–6201
Alitalo A, Meri T, Comstedt P, Jeffery L, Tornberg J, Strandin T, Lankinen H, Bergström S, Cinco M, Vuppala SR et al (2005) Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with neuroborreliosis. Eur J Immunol 35(10):3043–3053
Ben-Menachem G, Kubler-Kielb J, Coxon B, Yergey A, Schneerson R (2003) A newly discovered cholesteryl galactoside from Borrelia burgdorferi. Proc Natl Acad Sci USA 100(13):7913–7918
Bhide MR, Escudero R, Camafeita E, Gil H, Jado I, Anda P (2009) Complement factor H binding by different Lyme disease and relapsing fever Borrelia in animals and human. BMC Res Notes 2:134
Blom AM (2002) Structural and functional studies of complement inhibitor C4b-binding protein. Biochem Soc Trans 30(Pt 6):978–982
Brissette CA, Cooley AE, Burns LH, Riley SP, Verma A, Woodman ME, Bykowski T, Stevenson B (2008) Lyme borreliosis spirochete Erp proteins, their known host ligands, and potential roles in mammalian infection. Int J Med Microbiol 298(Suppl 1):257–267
Brissette CA, Haupt K, Barthel D, Cooley AE, Bowman A, Skerka C, Wallich R, Zipfel PF, Kraiczy P, Stevenson B (2009) Borrelia burgdorferi infection-associated surface proteins ErpP, ErpA, and ErpC bind human plasminogen. Infect Immun 77(1):300–306
Brooks CS, Vuppala SR, Jett AM, Alitalo A, Meri S, Akins DR (2005) Complement regulator-acquiring surface protein 1 imparts resistance to human serum in Borrelia burgdorferi. J Immunol 175(5):3299–3308
Bykowski T, Woodman ME, Cooley AE, Brissette CA, Brade V, Wallich R, Kraiczy P, Stevenson B (2007) Coordinated expression of Borrelia burgdorferi complement regulator-acquiring surface proteins during the Lyme disease spirochete’s mammal-tick infection cycle. Infect Immun 75(9):4227–4236
Casjens, S., R. van Vugt, K. Tilly, P. A. Rosa, and B. Stevenson (1997) Homology throughout the multiple 32-kilobase circular plasmids present in Lyme disease spirochetes. J Bacteriol 179(1):217-227
Casjens S, Palmer N, van Vugt R, Huang WM, Stevenson B, Rosa P, Lathigra R, Sutton G, Peterson J, Dodson RJ et al (2000) A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 35(3):490–516
Coleman AS, Yang X, Kumar M, Zhang X, Promnares K, Shroder D, Kenedy MR, Anderson JF, Akins DR, Pal U (2008) Borrelia burgdorferi complement regulator-acquiring surface protein 2 does not contribute to complement resistance or host infectivity. PLoS One 3(8):3010e
Cordes FS, Roversi P, Kraiczy P, Simon MM, Brade V, Jahraus O, Wallis R, Skerka C, Zipfel PF, Wallich R et al (2005) A novel fold for the factor H-binding protein BbCRASP-1 of Borrelia burgdorferi. Nat Struct Mol Biol 12(3):276–277
Cordes FS, Kraiczy P, Roversi P, Simon MM, Brade V, Jahraus O, Wallis R, Goodstadt L, Ponting CP, Skerka C et al (2006) Structure-function mapping of BbCRASP-1, the key complement factor H and FHL-1 binding protein of Borrelia burgdorferi. Int J Med Microbiol 296(Suppl 40):177–184
Dahlback B, Stenflo J (1981) High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci USA 78(4):2512–2516
Das S, Barthold SW, Giles SS, Montgomery RR, Telford SR III, Fikrig E (1997) Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host. J Clin Invest 99(5):987–995
Davis AE III, Mejia P, Lu F (2008) Biological activities of C1 inhibitor. Mol Immunol 45(16): 4057–4063
Dieterich R, Hammerschmidt C, Richter D, Skerka C, Wallich R, Matuschka FR, Zipfel PF, Kraiczy P (2010) Inadequate binding of immune regulator factor H is associated with sensitivity of Borrelia lusitaniae to human complement. Infect Immun 78(11):4467–4476
Dworkin MS, Schwan TG, Anderson DE Jr (2002) Tick-borne relapsing fever in North America. Med Clin North Am 86(2):417–433, viii–ix
Estaller C, Koistinen V, Schwaeble W, Dierich MP, Weiss EH (1991) Cloning of the 1.4-kb mRNA species of human complement factor H reveals a novel member of the short consensus repeat family related to the carboxy terminal of the classical 150-kDa molecule. J Immunol 146(9): 3190–3196
Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, White O, Ketchum KA, Dodson R, Hickey EK et al (1997) Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390(6660):580–586
Fujita T, Nussenzweig V (1979) The role of C4-binding protein and beta 1 H in proteolysis of C4b and C3b. J Exp Med 150(2):267–276
Fujita T, Gigli I, Nussenzweig V (1978) Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator. J Exp Med 148(4):1044–1051
Fujita T, Matsushita M, Endo Y (2004) The lectin-complement pathway—its role in innate immunity and evolution. Immunol Rev 198:185–202
Grosskinsky S, Schott M, Brenner C, Cutler SJ, Kraiczy P, Zipfel PF, Simon MM, Wallich R (2009) Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. PLoS One 4(3):e4858
Grosskinsky S, Schott M, Brenner C, Cutler SJ, Simon MM, Wallich R (2010) Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis. PLoS Negl Trop Dis 4(6):e698
Hallström T, Haupt K, Kraiczy P, Hortschansky P, Wallich R, Skerka C, Zipfel PF (2010) Complement regulator-acquiring surface protein 1 of Borrelia burgdorferi binds to human bone morphogenic protein 2, several extracellular matrix proteins, and plasminogen. J Infect Dis 202(3):490–498
Hammerschmidt C, Hallström T, Skerka C, Wallich R, Stevenson B, Zipfel PF, Kraiczy P (2012) Contribution of the infection-associated complement regulator-acquiring surface protein 4 (ErpC) to complement resistance of Borrelia burgdorferi. Clin Dev Immunol 2012:349657.
Harris CL, Rushmere NK, Morgan BP (1999) Molecular and functional analysis of mouse decay accelerating factor (CD55). Biochem J 341(Pt 3):821–829
Hartmann K, Corvey C, Skerka C, Kirschfink M, Karas M, Brade V, Miller JC, Stevenson B, Wallich R, Zipfel PF et al (2006) Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1. Mol Microbiol 61(5):1220–1236
Haupt K, Kraiczy P, Wallich R, Brade V, Skerka C, Zipfel P (2007) Binding of human factor H-related protein 1 to serum-resistant Borrelia burgdorferi is mediated by borrelial complement regulator-acquiring surface proteins. J Infect Dis 196(1):124–133
Hefty PS, Jolliff SE, Caimano MJ, Wikel SK, Radolf JD, Akins DR (2001) Regulation of OspE-related, OspF-related, and Elp lipoproteins of Borrelia burgdorferi strain 297 by mammalian host-specific signals. Infect Immun 69(6):3618–3627
Hefty PS, Brooks CS, Jett AM, White GL, Wikel SK, Kennedy RC, Akins DR (2002) OspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons experimentally infected with Borrelia burgdorferi and in human lyme disease patients. J Clin Microbiol 40(11):4256–4265
Heinen, S., A. Hartmann, N. Lauer, U. Wiehl, H. M. Dahse, S. Schirmer, K. Gropp, T. Enghardt, R. Wallich, S. Halbich, M. Mihlan, U. Schlotzer-Schrehardt, P. F. Zipfel, and C. Skerka (2009) Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 114(12):2439–2447
Hellwage J, Meri T, Heikkila T, Alitalo A, Panelius J, Lahdenne P, Seppala IJT, Meri S (2001) The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem 276(11):8427–8435
Herzberger P, Siegel C, Skerka C, Fingerle V, Schulte-Spechtel U, van Dam A, Wilske B, Brade V, Zipfel PF, Wallich R et al (2007) Human pathogenic Borrelia spielmanii sp. nov. resists complement-mediated killing by direct binding of immune regulators factor H and factor H-like protein 1. Infect Immun 75(10):4817–4825
Herzberger P, Siegel C, Skerka C, Fingerle V, Schulte-Spechtel U, Wilske B, Brade V, Zipfel PF, Wallich R, Kraiczy P (2009) Identification and characterization of the factor H and FHL-1 binding complement regulator-acquiring surface protein 1 of the Lyme disease spirochete Borrelia spielmanii sp. nov. Int J Med Microbiol 299(2):141–154
Hovis KM, McDowell JV, Griffin L, Marconi RT (2004) Identification and characterization of a linear-plasmid-encoded factor H-binding protein (FhbA) of the relapsing fever spirochete Borrelia hermsii. J Bacteriol 186(9):2612–2618
Hovis KM, Tran E, Sundy CM, Buckles E, McDowell JV, Marconi RT (2006a) Selective binding of Borrelia burgdorferi OspE paralogs to factor H and serum proteins from diverse animals: possible expansion of the role of OspE in Lyme disease pathogenesis. Infect Immun 74(3):1967–1972
Hovis KM, Jones JP, Sadlon T, Raval G, Gordon DL, Marconi RT (2006b) Molecular analyses of the interaction of Borrelia hermsii FhbA with the complement regulatory proteins factor H and factor H-like protein 1. Infect Immun 74(4):2007–2014
Hovis KM, Freedman JC, Zhang H, Forbes JL, Marconi RT (2008) Identification of an antiparallel coiled-coil/loop domain required for ligand binding by the Borrelia hermsii FhbA protein: additional evidence for the role of FhbA in the host-pathogen interaction. Infect Immun 76(5):2113–2122
Iyer R, Liveris D, Adams A, Nowakowski J, McKenna D, Bittker S, Cooper D, Wormser GP, Schwartz I (2001) Characterization of Borrelia burgdorferi isolated from erythema migrans lesions: interrelationship of three molecular typing methods. J Clin Microbiol 39(8):2954–2957
Józsi M, Zipfel PF (2008) Factor H family proteins and human diseases. Trends Immunol 29(8):380–387
Kenedy MR, Akins DR (2011) The OspE-related proteins inhibit complement deposition and enhance serum resistance of Borrelia burgdorferi, the Lyme disease spirochete. Infect Immun 79(4):1451–1457
Kenedy MR, Vuppala SR, Siegel C, Kraiczy P, Akins DR (2009) CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi. Infect Immun 77(7):2773–2782
Kirjavainen V, Jarva H, Biedzka-Sarek M, Blom AM, Skurnik M, Meri S (2008) Yersinia enterocolitica serum resistance proteins YadA and Ail bind the complement regulator C4b-binding protein. PLoS Pathog 4(8):e1000140
Kisova-Vargova L, Mucha R, Cernanka D, Bhide M (2011) Host-dependent differential expression of factor H binding proteins, their affinity to factor H and complement evasion by Lyme and relapsing fever borreliae. Vet Microbiol 148(2–4):341–347
Kraiczy P, Skerka C, Brade V, Zipfel PF (2001a) Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi. Infect Immun 69(12):7800–7809
Kraiczy P, Skerka C, Kirschfink M, Brade V, Zipfel Peter F (2001b) Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H. Eur J Immunol 31(6):1674–1684
Kraiczy P, Skerka C, Zipfel PF, Brade V (2002) Complement regulator-acquiring surface proteins of Borrelia burgdorferi: a new protein family involved in complement resistance. Wien Klin Wochenschr 114(13–14):568–573
Kraiczy P, Hellwage J, Skerka C, Kirschfink M, Brade V, Zipfel PF, Wallich R (2003) Immune evasion of Borrelia burgdorferi: mapping of a complement-inhibitor factor H-binding site of BbCRASP-3, a novel member of the Erp protein family. Eur J Immunol 33(3):697–707
Kraiczy P, Hellwage J, Skerka C, Becker H, Kirschfink M, Simon MM, Brade V, Zipfel PF, Wallich R (2004a) Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J Biol Chem 279(4):2421–2429
Kraiczy P, Hartmann K, Hellwage J, Skerka C, Kirschfink M, Brade V, Zipfel PF, Wallich R, Stevenson B (2004b) Immunological characterization of the complement regulator factor H-binding CRASP and Erp proteins of Borrelia burgdorferi. Int J Med Microbiol 293(37):152–157
Kraiczy P, Rossmann E, Brade V, Simon MM, Skerka C, Zipfel PF, Wallich R (2006) Binding of human complement regulators FHL-1 and factor H to CRASP-1 orthologs of Borrelia burgdorferi. Wien Klin Wochenschr 118(21–22):669–676
Kraiczy P, Seling A, Brissette CA, Rossmann E, Hunfeld KP, Bykowski T, Burns LH, Troese MJ, Cooley AE, Miller JC et al (2008) Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease. Clin Vaccine Immunol 15(3):484–491
Kraiczy P, Hanssen-Hubner C, Kitiratschky V, Brenner C, Besier S, Brade V, Simon MM, Skerka C, Roversi P, Lea SM et al (2009) Mutational analyses of the BbCRASP-1 protein of Borrelia burgdorferi identify residues relevant for the architecture and binding of host complement regulators FHL-1 and factor H. Int J Med Microbiol 299(4):255–268
Lam TT, Nguyen TP, Montgomery RR, Kantor FS, Fikrig E, Flavell RA (1994) Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease. Infect Immun 62(1):290–298
Larsson C, Lundqvist J, van Rooijen N, Bergstrom S (2009) A novel animal model of Borrelia recurrentis louse-borne relapsing fever borreliosis using immunodeficient mice. PLoS Negl Trop Dis 3(9):e522
Lederer S, Brenner C, Stehle T, Gern L, Wallich R, Simon MM (2005) Quantitative analysis of Borrelia burgdorferi gene expression in naturally (tick) infected mouse strains. Med Microbiol Immunol 194(1–2):81–90
Lescot M, Audic S, Robert C, Nguyen TT, Blanc G, Cutler SJ, Wincker P, Couloux A, Claverie JM, Raoult D et al (2008) The genome of Borrelia recurrentis, the agent of deadly louse-borne relapsing fever, is a degraded subset of tick-borne Borrelia duttonii. PLoS Genet 4(9):e1000185
Ma YJ, Doni A, Hummelshoj T, Honore C, Bastone A, Mantovani A, Thielens NM, Garred P (2009) Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition. J Biol Chem 284(41):28263–28275
McDowell JV, Sung SY, Labandeira-Rey M, Skare JT, Marconi RT (2001a) Analysis of mechanisms associated with loss of infectivity of clonal populations of Borrelia burgdorferi B31MI. Infect Immun 69(6):3670–3677
McDowell JV, Sung SY, Price G, Marconi RT (2001b) Demonstration of the genetic stability and temporal expression of select members of the lyme disease spirochete OspF protein family during infection in mice. Infect Immun 69(8):4831–4838
McDowell JV, Wolfgang J, Tran E, Metts MS, Hamilton D, Marconi RT (2003a) Comprehensive analysis of the factor H binding capabilities of Borrelia species associated with Lyme disease: delineation of two distinct classes of factor H binding proteins. Infect Immun 71(6): 3597–3602
McDowell JV, Tran E, Hamilton D, Wolfgang J, Miller K, Marconi RT (2003b) Analysis of the ability of spirochete species associated with relapsing fever, avian borreliosis, and epizootic bovine abortion to bind factor H and cleave C3b. J Clin Microbiol 41(8):3905–3910
McDowell JV, Wolfgang J, Senty L, Sundy CM, Noto MJ, Marconi RT (2004) Demonstration of the involvement of outer surface protein E coiled-coil structural domains and higher order structural elements in the binding of infection-induced antibody and the complement-regulatory protein, factor H. J Immunol 173(12):7471–7480
McDowell JV, Harlin ME, Rogers EA, Marconi RT (2005) Putative coiled-coil structural elements of the BBA68 protein of Lyme disease spirochetes are required for formation of its factor H binding site. J Bacteriol 187(4):1317–1323
McDowell JV, Hovis KM, Zhang H, Tran E, Lankford J, Marconi RT (2006) Evidence that the BBA68 protein (BbCRASP-1) of the Lyme disease spirochetes does not contribute to factor H-mediated immune evasion in humans and other animals. Infect Immun 74(5):3030–3034
McRae JL, Cowan PJ, Power DA, Mitchelhill KI, Kemp BE, Morgan BP, Murphy BF (2001) Human factor H-related protein 5 (FHR-5). A new complement-associated protein. J Biol Chem 276(9):6747–6754
McRae JL, Duthy TG, Griggs KM, Ormsby RJ, Cowan PJ, Cromer BA, McKinstry WJ, Parker MW, Murphy BF, Gordon DL (2005) Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J Immunol 174(10):6250–6256
Meri T, Cutler SJ, Blom AM, Meri S, Jokiranta TS (2006) Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H. Infect Immun 74(7):4157–4163
Metts MS, McDowell JV, Theisen M, Hansen PR, Marconi RT (2003) Analysis of the OspE determinants involved in binding of factor H and OspE-targeting antibodies elicited during Borrelia burgdorferi infection in mice. Infect Immun 71(6):3587–3596
Miller JC, Stevenson B (2006) Borrelia burgdorferi erp genes are expressed at different levels within tissues of chronically infected mammalian hosts. Int J Med Microbiol 296(Suppl 40):185–194
Miller JC, von Lackum K, Babb K, McAlister JD, Stevenson B (2003) Temporal analysis of Borrelia burgdorferi Erp protein expression throughout the mammal-tick infectious cycle. Infect Immun 71(12):6943–6952
Nagasawa S, Mizuguchi K, Ichihara C, Koyama J (1982) Limited chymotryptic cleavage of human C4-binding protein: isolation of a carbohydrate-containing core domain and an active fragment. J Biochem 92(4):1329–1332
Nguyen TP, Lam TT, Barthold SW, Telford SR III, Flavell RA, Fikrig E (1994) Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice. Infect Immun 62(5):2079–2084
Nordstrom T, Blom AM, Forsgren A, Riesbeck K (2004) The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2. J Immunol 173(7):4598–4606
Norman MU, Moriarty TJ, Dresser AR, Millen B, Kubes P, Chaconas G (2008) Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS Pathog 4(10):e1000169
Pietikainen J, Meri T, Blom AM, Meri S (2010) Binding of the complement inhibitor C4b-binding protein to Lyme disease Borreliae. Mol Immunol 47(6):1299–1305
Porcella SF, Raffel SJ, Anderson DE Jr, Gilk SD, Bono JL, Schrumpf ME, Schwan TG (2005) Variable tick protein in two genomic groups of the relapsing fever spirochete Borrelia hermsii in western North America. Infect Immun 73(10):6647–6658
Prasadarao NV, Blom AM, Villoutreix BO, Linsangan LC (2002) A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1. J Immunol 169(11):6352–6360
Ram S, Cullinane M, Blom AM, Gulati S, McQuillen DP, Boden R, Monks BG, O’Connell C, Elkins C, Pangburn MK et al (2001a) C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae. Int Immunopharmacol 1(3):423–432
Ram S, Cullinane M, Blom AM, Gulati S, McQuillen DP, Monks BG, O’Connell C, Boden R, Elkins C, Pangburn MK et al (2001b) Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J Exp Med 193(3):281–295
Rogers EA, Marconi RT (2007) Delineation of species-specific binding properties of the CspZ protein (BBH06) of Lyme disease spirochetes: evidence for new contributions to the pathogenesis of Borrelia spp. Infect Immun 75(11):5272–5281
Rogers EA, Abdunnur SV, McDowell JV, Marconi RT (2009) Comparative analysis of the properties and ligand binding characteristics of CspZ, a factor H binding protein, derived from Borrelia burgdorferi isolates of human origin. Infect Immun 77(10):4396–4405
Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP, van Strijp JA (2005) Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 6(9):920–927
Rossmann E, Kitiratschky V, Hofmann H, Kraiczy P, Simon MM, Wallich R (2006) Borrelia burgdorferi complement regulator-acquiring surface protein 1 of the Lyme disease spirochetes is expressed in humans and induces antibody responses restricted to nondenatured structural determinants. Infect Immun 74(12):7024–7028
Rossmann E, Kraiczy P, Herzberger P, Skerka C, Kirschfink M, Simon MM, Zipfel PF, Wallich R (2007) Dual binding specificity of a Borrelia hermsii-associated complement regulator-acquiring surface protein for factor H and plasminogen discloses a putative virulence factor of relapsing fever spirochetes. J Immunol 178(11):7292–7301
Scharfstein J, Ferreira A, Gigli I, Nussenzweig V (1978) Human C4-binding protein. I. Isolation and characterization. J Exp Med 148(1):207–222
Schott M, Grosskinsky S, Brenner C, Kraiczy P, Wallich R (2010) Molecular characterization of the interaction of Borrelia parkeri and Borrelia turicatae with human complement regulators. Infect Immun 78(5):2199–2208
Schutzer SE, Fraser-Liggett CM, Casjens SR, Qiu WG, Dunn JJ, Mongodin EF, Luft BJ (2011) Whole genome sequences of thirteen isolates of Borrelia burgdorferi. J Bacteriol 193(4): 1018–1020
Schwalbe R, Dahlback B, Hillarp A, Nelsestuen G (1990a) Assembly of protein S and C4b-binding protein on membranes. J Biol Chem 265(27):16074–16081
Schwalbe RA, Dahlback B, Nelsestuen GL (1990b) Independent association of serum amyloid P component, protein S, and complement C4b with complement C4b-binding protein and subsequent association of the complex with membranes. J Biol Chem 265(35):21749–21757
Seling A, Siegel C, Fingerle V, Jutras BL, Brissette CA, Skerka C, Wallich R, Zipfel PF, Stevenson B, Kraiczy P (2010) Functional characterization of Borrelia spielmanii outer surface proteins that interact with distinct members of the human factor H protein family and with plasminogen. Infect Immun 78(1):39–48
Siegel C, Schreiber J, Haupt K, Skerka C, Brade V, Simon MM, Stevenson B, Wallich R, Zipfel PF, Kraiczy P (2008) Deciphering the ligand-binding sites in the Borrelia burgdorferi complement regulator-acquiring surface protein 2 required for interactions with the human immune regulators factor H and factor H-like protein 1. J Biol Chem 283(50):34855–34863
Siegel C, Hallström T, Skerka C, Eberhardt H, Uzonyi B, Beckhaus T, Karas M, Wallich R, Stevenson B, Zipfel PF et al (2010) Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi. PLoS One 5(10):e13519
Skerka C, Zipfel PF (2008) Complement factor H related proteins in immune diseases. Vaccine 26(Suppl 8):I9–I14
Skerka C, Horstmann RD, Zipfel PF (1991) Molecular cloning of a human serum protein structurally related to complement factor H. J Biol Chem 266(18):12015–12020
Skerka C, Timmann C, Horstmann RD, Zipfel PF (1992) Two additional human serum proteins structurally related to complement factor H. Evidence for a family of factor H-related genes. J Immunol 148(10):3313–3318
Stevenson B (2001) Borrelia burgdorferi: a (somewhat) clonal bacterial species. Trends Microbiol 9(10):471–472
Stevenson B (2002) Borrelia burgdorferi erp (ospE-related) gene sequences remain stable during mammalian infection. Infect Immun 70(9):5307–5311
Stevenson B, Miller JC (2003) Intra- and interbacterial genetic exchange of Lyme disease spirochete erp genes generates sequence identity amidst diversity. J Mol Evol 57(3):309–324
Stevenson B, Schwan TG, Rosa PA (1995) Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 63(11):4535–4539
Stevenson B, Tilly K, Rosa PA (1996) A family of genes located on four separate 32-kilobase circular plasmids in Borrelia burgdorferi B31. J Bacteriol 178(12):3508–3516
Stevenson B, Bono JL, Schwan TG, Rosa P (1998) Borrelia burgdorferi Erp proteins are immunogenic in mammals infected by tick bite, and their synthesis is inducible in cultured bacteria. Infect Immun 66(6):2648–2654
Stevenson B, Zückert WR, Akins DR (2001) Repetition, conservation, and variation: the multiple cp32 plasmids of Borrelia species. In: Saier MH, Garcia-Lara J (eds) The spirochetes: molecular and cellular biology. Horizon Press, Oxford, pp 87–100
Stevenson B, El-Hage N, Hines MA, Miller JC, Babb K (2002) Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes. Infect Immun 70(2):491–497
Stevenson B, Bykowski T, Cooley AE, Babb K, Miller JC, Woodman ME, von Lakum K, Riley SP (2006) The Lyme disease spirochetes Erp protein family: structure, function, and regulation of gene expression. In: Cabello FC, Godfrey HP, Hulinska D (eds) Molecular biology of spirochetes. Ios Press, Amsterdam, pp 352–372
Stubs G, Fingerle V, Wilske B, Gobel UB, Zahringer U, Schumann RR, Schroder NW (2009) Acylated cholesteryl galactosides are specific antigens of Borrelia causing lyme disease and frequently induce antibodies in late stages of disease. J Biol Chem 284(20):13326–13334
van Burgel ND, Kraiczy P, Schuijt TJ, Zipfel PF, van Dam AP (2010) Identification and functional characterisation of complement regulator acquiring surface protein-1 of serum resistant Borrelia garinii OspA serotype 4. BMC Microbiol 10:43
von Lackum K, Miller JC, Bykowski T, Riley SP, Woodman ME, Brade V, Kraiczy P, Stevenson B, Wallich R (2005) Borrelia burgdorferi regulates expression of complement regulator-acquiring surface protein 1 during the mammal-tick infection cycle. Infect Immun 73(11):7398–7405
Wallich R, Brenner C, Kramer MD, Simon MM (1995) Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo. Infect Immun 63(9):3327–3335
Wallich R, Jahraus O, Stehle T, Tran TT, Brenner C, Hofmann H, Gern L, Simon MM (2003) Artificial-infection protocols allow immunodetection of novel Borrelia burgdorferi antigens suitable as vaccine candidates against Lyme disease. Eur J Immunol 33(3):708–719
Wallich R, Pattathu J, Kitiratschky V, Brenner C, Zipfel PF, Brade V, Simon MM, Kraiczy P (2005) Identification and functional characterization of complement regulator-acquiring surface protein 1 of the Lyme disease spirochetes Borrelia afzelii and Borrelia garinii. Infect Immun 73(4):2351–2359
Walport MJ (2001) Complement—first of two parts. N Engl J Med 344(14):1058–1066
Wormser GP, Brisson D, Liveris D, Hanincova K, Sandigursky S, Nowakowski J, Nadelman RB, Ludin S, Schwartz I (2008) Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis 198(9):1358–1364
Wywial E, Haven J, Casjens SR, Hernandez YA, Singh S, Mongodin EF, Fraser-Liggett CM, Luft BJ, Schutzer SE, Qiu WG (2009) Fast, adaptive evolution at a bacterial host-resistance locus: the PFam54 gene array in Borrelia burgdorferi. Gene 445(1–2):26–37
Zipfel PF (2009) Complement and immune defense: from innate immunity to human diseases. Immunol Lett 126:1–7
Zipfel PF, Skerka C (2009) Complement regulators and inhibitory proteins. Nat Rev Immunol 9(10):729–740
Zipfel PF, Skerka C, Hellwage J, Jokiranta ST, Meri S, Brade V, Kraiczy P, Noris M, Remuzzi G (2002) Factor H family proteins: on complement, microbes and human diseases. Biochem Soc Trans 30(Pt 6):971–978
Acknowledgments
We want to thank all of our colleagues whose research has contributed to an increased understanding of the role of borrelial complement-binding proteins in immune evasion of these emerging pathogens. Many thanks to Brian Stevenson for critical review of the manuscript and fruitful discussions, and Arno Koenigs for help with the graphics. Research in the authors’ labs was supported by the Deutsche Forschungsgemeinschaft (Kr3383/1-2, Wa533/7-1, and Wa533/8-1).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kraiczy, P., Wallich, R. (2012). Borrelial Complement-Binding Proteins. In: Embers, M. (eds) The Pathogenic Spirochetes: strategies for evasion of host immunity and persistence. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-5404-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5404-5_4
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-5403-8
Online ISBN: 978-1-4614-5404-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)